CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green? Thamizhselvi GanapathyRajalingam RadhakrishnanSunil Martin Review Article 12 August 2022 Pages: 277 - 286
Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens Helen ChoJoe BinderRobert E. Hollingsworth Original Article 13 July 2022 Pages: 287 - 300
Personalized tumor vaccine for pancreatic cancer Shira OrrLing HuangDavid Avigan Original Article 14 July 2022 Pages: 301 - 313
High abundance of Lachnospiraceae in the human gut microbiome is related to high immunoscores in advanced colorectal cancer Zhang HexunToru MiyakeMasaji Tani Original Article 22 July 2022 Pages: 315 - 326
Interleukin-32Îł promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma Haimeng YanDonghua HeZhen Cai Original Article 26 July 2022 Pages: 327 - 338
Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer Yinjie GaoMichelle M. SteinSandip P. Patel Original Article Open access 26 July 2022 Pages: 339 - 350
A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment Cheng-Liang KuoHan-Yu ChouAlan Yueh-Luen Lee Original Article Open access 27 July 2022 Pages: 351 - 369
Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma Seung Hyuck JeonYong Joon LeeEui-Cheol Shin Original Article 28 July 2022 Pages: 371 - 384
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy Mengchao AnWenkang WangZibing Wang Original Article 30 July 2022 Pages: 385 - 395
Single-cell analysis of peripheral CD8+ T cell responses in patients receiving checkpoint blockade immunotherapy for cancer Niloufar KhojandiLouis ConnellyRyan M. Teague Original Article 30 July 2022 Pages: 397 - 408
Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer Jiannan ChenJianhua HuZhigang Guo Original Article 04 August 2022 Pages: 409 - 425
Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab Tatsuki IkomaMototsugu ShimokawaHironaga Satake Original Article 04 August 2022 Pages: 427 - 435
Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients Shumin YuanLing PengZibing Wang Original Article 05 August 2022 Pages: 437 - 448
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients Yu FengLe TangYuankai Shi Original Article 07 August 2022 Pages: 449 - 459
Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma Kasper Munch LauridsenMarianne HoklandMorten Nørgaard Andersen Original Article 11 August 2022 Pages: 461 - 473
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study Emiel A. De JaeghereSandra TuyaertsHannelore G. Denys Original Article Open access 12 August 2022 Pages: 475 - 491
Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies Jie WangChen LiFeng Guo Original Article 13 August 2022 Pages: 493 - 507
Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma Xin-Wen ZhangAlexander WaldJessica C. Hassel Research Report Open access 16 July 2022 Pages: 509 - 513
Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphoma Alexej BallhausenAmin Ben HamzaLeo Hansmann Research Report Open access 10 August 2022 Pages: 515 - 521
Bloody pericardial effusion during chemotherapy with immune checkpoint inhibitors Yuika SasataniEiji OjimaHiroaki Satoh Letter to the Editors 25 July 2022 Pages: 523 - 525